Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

233.01
+1.490.64%
Post-market: 233.010.00000.00%19:30 EDT
Volume:740.58K
Turnover:172.57M
Market Cap:15.13B
PE:15.93
High:234.47
Open:230.33
Low:229.85
Close:231.52
52wk High:266.38
52wk Low:128.80
Shares:64.91M
Float Shares:62.69M
Volume Ratio:0.87
T/O Rate:1.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.15
PE(LYR):-39.90

Loading ...

Aug 26, 2026

Major Issues Report

Form 8-K - Current report
Aug 10, 2026

Major Issues Report

Form 8-K - Current report
Aug 10, 2026

Major Issues Report

Form 8-K - Current report
Aug 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2026

Major Issues Report

Form 8-K - Current report
Jul 24, 2026

Major Issues Report

Form 8-K - Current report
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2026

Major Issues Report

Form 8-K - Current report
May 28, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 28, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 05, 2026

Major Issues Report

Form 8-K - Current report
May 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]